A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS) – the most common form of the illness, in which symptoms wax and wane.

New research by neuroscientists at the University of Pittsburgh and UC San Francisco revealed that a simple, earbud-like device developed at UCSF that imperceptibly stimulates a key nerve leading to the brain could significantly improve the wearer’s ability to learn the sounds of a new language.

As the official medical provider of the 2020 PGA Championship in San Francisco, UCSF Sports Medicine staff will be on-site to provide general first aid and immediate medical assistance.

The COVID-19 pandemic has led to a significant increase in video visits between patients and their doctors, but for many older adults, the shift has cut them off from care, rather than connecting them.

It’s likely that face masks, by blocking even some of the coronavirus-carrying droplets you inhale, can reduce your risk of falling seriously ill from COVID-19, according to Monica Gandhi, an infectious disease specialist at UCSF.

A vendor that UCSF uses for trend analysis of donations to the university informed us it had experienced an IT security incident in May 2020 that exposed some UCSF information.

In San Francisco’s Mission District, UCSF infectious disease specialists and community partners are launching what is believed to be a first-in-the-nation pilot program to provide low-barrier COVID-19 testing — free, simple, and convenient — at a central transit hub.